A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis (Q95568947)
Jump to navigation
Jump to search
scientific article published on 23 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis |
scientific article published on 23 March 2016 |
Statements
A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis (English)
Leif E Dahlberg
Aida Aydemir
Norma Muurahainen
Hans Gühring
Helena Fredberg Edebo
Niels Krarup-Jensen
Christoph H Ladel